China Resources Pharmaceutical Group Limited (HKG:3320)

HKG:3320 Revenue

China Resources Pharmaceutical Group had revenue of 134.46B CNY in the half year ending June 30, 2026, with 4.56% growth. This brings the company's total for the last twelve months to 272.17B, up 4.30% year-over-year. In the year 2025, China Resources Pharmaceutical Group had annual revenue of 269.57B with 4.62% growth. That makes China Resources Pharmaceutical Group the 338th largest company in the world by revenue and 33rd in Hong Kong.

• Revenue (ttm): 272.17B CNY
• Revenue Growth: +4.30%
• P/S Ratio: 0.09
• Revenue / Employee: 3.24M CNY
• Employees: 84,000
• Market Cap: 27.96B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue by Segment

By Segment

Chart

• Distribution 220.08B 77.7%
• Manufacturing 51.04B 18.0%
• Retail 12.21B 4.3%
• Others 93.25M 0.0%

By Geography

Chart

• Mainland China 268.51B 99.6%
• Others 1.07B 0.4%

Fiscal year ended Dec 31, 2025 See the full HKG:3320 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	269.57B	11.90B	4.62%
Dec 31, 2024	257.67B	12.97B	5.30%
Dec 31, 2023	244.70B	26.52B	12.16%
Dec 31, 2022	218.18B	25.26B	13.10%
Dec 31, 2021	192.92B	24.16B	14.31%

Data Source: S&P Global Market Intelligence Last updated: Sep 24, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 21, 2026

Data Sources Report a data error